Correlation Between Cognition Therapeutics and Phio Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Cognition Therapeutics and Phio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognition Therapeutics and Phio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cognition Therapeutics and Phio Pharmaceuticals Corp, you can compare the effects of market volatilities on Cognition Therapeutics and Phio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognition Therapeutics with a short position of Phio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognition Therapeutics and Phio Pharmaceuticals.

Diversification Opportunities for Cognition Therapeutics and Phio Pharmaceuticals

-0.29

Correlation Coefficient

Cognition Therapeutics  Phio Pharmaceuticals

Very good diversification

The 3 months correlation between Cognition and Phio is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and Phio Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phio Pharmaceuticals Corp and Cognition Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognition Therapeutics are associated (or correlated) with Phio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phio Pharmaceuticals Corp has no effect on the direction of Cognition Therapeutics i.e., Cognition Therapeutics and Phio Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cognition Therapeutics and Phio Pharmaceuticals

Given the investment horizon of 90 days Cognition Therapeutics is expected to generate 1.17 times more return on investment than Phio Pharmaceuticals. However, Cognition Therapeutics is 1.17 times more volatile than Phio Pharmaceuticals Corp. It trades about -0.04 of its potential returns per unit of risk. Phio Pharmaceuticals Corp is currently generating about -0.09 per unit of risk. If you would invest  186.00  in Cognition Therapeutics on October 8, 2024 and sell it today you would lose (110.00) from holding Cognition Therapeutics or give up 59.14% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cognition Therapeutics  vs.  Phio Pharmaceuticals Corp

Cognition Therapeutics

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Cognition Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Cognition Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Phio Pharmaceuticals Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Phio Pharmaceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Cognition Therapeutics and Phio Pharmaceuticals

The main advantage of trading using opposite Cognition Therapeutics and Phio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognition Therapeutics position performs unexpectedly, Phio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will offset losses from the drop in Phio Pharmaceuticals' long position.

The idea behind Cognition Therapeutics and Phio Pharmaceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.